Literature DB >> 10074157

Early region 1 transforming functions are dispensable for mammary tumorigenesis by human adenovirus type 9.

D L Thomas1, S Shin, B H Jiang, H Vogel, M A Ross, M Kaplitt, T E Shenk, R T Javier.   

Abstract

Some human adenoviruses are tumorigenic in rodents. Subgroup A and B human adenoviruses generally induce sarcomas in both male and female animals, and the gene products encoded within viral early region 1 (E1 region) are both necessary and sufficient for this tumorigenicity. In contrast, subgroup D human adenovirus type 9 (Ad9) induces estrogen-dependent mammary tumors in female rats and requires the E4 region-encoded ORF1 oncoprotein for its tumorigenicity. Considering the established importance of the viral E1 region for tumorigenesis by adenoviruses, we investigated whether this viral transcription unit is also necessary for Ad9 to generate mammary tumors. The nucleotide sequence of the Ad9 E1 region indicated that the gene organization and predicted E1A and E1B polypeptides of Ad9 are closely related to those of other human adenovirus E1 regions. In addition, an Ad9 E1 region plasmid demonstrated focus-forming activity in both low-passage-number and established rat embryo fibroblasts, whereas a large deletion within either the E1A or E1B gene of this plasmid diminished transforming activity. Surprisingly, we found that introducing the same transformation-inactivating E1A and E1B deletions into Ad9 results in mutant viruses that retain the ability to elicit mammary tumors in rats. These results are novel in showing that Ad9 represents a unique oncogenic adenovirus in which the E4 region, rather than the E1 region, encodes the major oncogenic determinant in the rat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074157      PMCID: PMC104067     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  An adenovirus type 5 early gene function regulates expression of other early viral genes.

Authors:  N Jones; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Deletion mutants of region E1a of AD12 E1 plasmids: effect on oncogenic transformation.

Authors:  J L Bos; A G Jochemsen; R Bernards; P I Schrier; H van Ormondt; A J van der Eb
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

5.  Expression of region E1b of human adenoviruses in the absence of region E1a is not sufficient for complete transformation.

Authors:  P Van den Elsen; A Houweling; A Van der Eb
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

6.  Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes.

Authors:  O Danos; L W Engel; E Y Chen; M Yaniv; P M Howley
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

7.  Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF).

Authors:  P B Fisher; L E Babiss; I B Weinstein; H S Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

8.  Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

Authors:  J R Nevins
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

9.  Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

Authors:  A Houweling; P J van den Elsen; A J van der Eb
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

10.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

View more
  13 in total

1.  Several E4 region functions influence mammary tumorigenesis by human adenovirus type 9.

Authors:  D L Thomas; J Schaack; H Vogel; R Javier
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.

Authors:  B A Glaunsinger; S S Lee; M Thomas; L Banks; R Javier
Journal:  Oncogene       Date:  2000-11-02       Impact factor: 9.867

3.  Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins.

Authors:  S S Lee; B Glaunsinger; F Mantovani; L Banks; R T Javier
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein.

Authors:  Kristopher K Frese; Siu Sylvia Lee; Darby L Thomas; Isabel J Latorre; Robert S Weiss; Britt A Glaunsinger; Ronald T Javier
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

5.  A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles.

Authors:  Sang-Hyuk Chung; Kristopher K Frese; Robert S Weiss; B V Venkataram Prasad; Ronald T Javier
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  Hijacking Dlg1 for oncogenic phosphatidylinositol 3-kinase activation in human epithelial cells is a conserved mechanism of human adenovirus E4-ORF1 proteins.

Authors:  Manish Kumar; Kathleen Kong; Ronald T Javier
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

7.  Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2.

Authors:  B A Glaunsinger; R S Weiss; S S Lee; R Javier
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

8.  Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein.

Authors:  M Nevels; S Rubenwolf; T Spruss; H Wolf; T Dobner
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  Corneal cell survival in adenovirus type 19 infection requires phosphoinositide 3-kinase/Akt activation.

Authors:  Maitreyi S Rajala; Raju V S Rajala; Roger A Astley; Amir L Butt; James Chodosh
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

10.  Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression.

Authors:  Kathleen Kong; Manish Kumar; Midori Taruishi; Ronald T Javier
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.